Followers | 28 |
Posts | 4560 |
Boards Moderated | 1 |
Alias Born | 09/22/2006 |
Friday, September 02, 2022 4:14:36 PM
I hate when that happens. LOL.
Looks like there is some support at around ~$37 and, with continuing overall market weakness and no company specific news, we might drift in that direction.
The good news is that this is low volume stuff and there is no sign that the big players are getting out, so there's that. In some sense current pps is just noise, but sooner or later Helen's got to start delivering or we'll eventually see the institutions loose patience and move on to greener prospects. (The Antares acquisition is just way too speculative at this point to be able to point to that as a sign of her wise probity.)
What are you seeing as far as potential near term catalysts?
The more you know, the less you don't know.
Recent HALO News
- Form 8-K - Current report • Edgar (US Regulatory) • 01/08/2025 01:00:20 PM
- Halozyme Reiterates 2024 Financial Guidance and Raises 2025 and Multi-Year Financial Guidance • PR Newswire (US) • 01/08/2025 12:00:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/07/2025 09:14:03 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/06/2025 10:12:58 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 01/06/2025 09:26:51 PM
- Halozyme to Host Investor Conference Call to Provide Updated 2025 Financial Guidance • PR Newswire (US) • 01/06/2025 01:30:00 PM
- Halozyme Announces Takeda Received Regulatory Approval for HYQVIA® 10% Subcutaneous Injection Set with ENHANZE® in Japan for Patients with Agammaglobulinemia or Hypogammaglobulinemia • PR Newswire (US) • 12/30/2024 12:00:00 PM
- Halozyme Announces argenx's VYDURA with ENHANZE® was Granted Regulatory Approval in Japan for Chronic Inflammatory Demyelinating Polyneuropathy • PR Newswire (US) • 12/30/2024 11:45:00 AM
- Halozyme Announces FDA Approval of Bristol Myers Squibb's Opdivo Qvantig™ with ENHANZE® for Subcutaneous Use in Most Previously Approved Adult Solid Tumor Opdivo® (nivolumab) Indications • PR Newswire (US) • 12/30/2024 11:30:00 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 12/03/2024 09:05:40 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 12/03/2024 09:04:05 PM
- Halozyme to Present at Upcoming Investor Conferences • PR Newswire (US) • 11/27/2024 01:30:00 PM
- Halozyme Withdraws Proposal to Acquire Evotec Following Evotec's Unwillingness to Engage in Discussions • PR Newswire (US) • 11/22/2024 01:35:00 PM
- Halozyme Confirms Proposal to Combine with Evotec for €11.00 Per Share in an All-Cash Transaction • PR Newswire (US) • 11/14/2024 09:15:00 PM
- Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend] • Edgar (US Regulatory) • 11/12/2024 02:36:57 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/31/2024 08:05:56 PM
- HALOZYME REPORTS THIRD QUARTER 2024 FINANCIAL AND OPERATING RESULTS • PR Newswire (US) • 10/31/2024 08:01:00 PM
- HALOZYME PROVIDES UPDATE ON LICENSEE CO-FORMULATION PATENT HEARING IN EUROPE • PR Newswire (US) • 10/24/2024 10:30:00 AM
- Halozyme to Report Third Quarter 2024 Financial and Operating Results • PR Newswire (US) • 10/23/2024 08:30:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 10/16/2024 10:53:48 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 10/16/2024 08:14:21 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 10/15/2024 08:34:07 PM
- ZenaTech, Inc. (NASDAQ: ZENA) Launchs IQ Nano Drone for Commercial Indoor Use • InvestorsHub NewsWire • 10/10/2024 12:09:56 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 10/09/2024 09:39:44 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 10/09/2024 08:09:23 PM
FEATURED Cannabix and AlcoPro Enter MOU for Marijuana Breathalyzer Marketing • Jan 24, 2025 8:49 AM
UC Asset Announces Plan of Secondary Public Offering via Reg A • UCASU • Jan 23, 2025 9:30 AM
Luke Plants Featured in U.S. Department of the Interior Report to Congress on Strategic Review of National Orphan Well Program • ZEFIF • Jan 21, 2025 10:51 AM
North Bay Resources Acquires 70% Interest in the Bishop Gold Mill, Inyo County, California • NBRI • Jan 21, 2025 9:26 AM
HealthLynked Unveils Release of ARi: A Revolutionary AI-Powered Healthcare Assistant • HLYK • Jan 21, 2025 8:00 AM
Good Gaming Inc. Announces ViaOne Services' Intent to Purchase Up to 10% of Its Common Shares in the Open Market • GMER • Jan 16, 2025 8:30 AM